On this page
Nasal Allergy
Triamcinolone acetonide · Spray, Metered
Overview
Active ingredients
Source: NDC Directory| Ingredient | Strength | RxCUI | Monograph |
|---|---|---|---|
| Triamcinolone Acetonide | 55 ug/1 | 1014314 | View |
Forms, strengths and routes
Source: NDC DirectoryPharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Corticosteroid Hormone Receptor Agonists [MoA] | MoA | All 215 members |
| Corticosteroid [EPC] | EPC | All 215 members |
Regulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 078104-001 | TRIAMCINOLONE ACETONIDE | SPRAY, METERED | TRIAMCINOLONE ACETONIDE | Discontinued | — | ||
| 078104-002 | TRIAMCINOLONE ACETONIDE | SPRAY, METERED | TRIAMCINOLONE ACETONIDE | Over-the-counter | — |
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 17 | Labeling | Approved | November 12, 2020 | Standard |
| Supplement | 11 | Labeling | Approved | November 12, 2020 | Standard |
| Supplement | 6 | Labeling | Approved | November 12, 2020 | Standard |
| Supplement | 7 | Manufacturing (CMC) | Approved | May 25, 2018 | — |
| Supplement | 3 | Labeling | Approved | November 14, 2014 | Standard |
| Original application | 1 | Approved | July 30, 2009 | — |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260805). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingUses temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • sneezing • itchy nose
Purpose
openFDA Drug LabelingPurpose Allergy symptom reliever
Dosage and Administration
openFDA Drug LabelingDirections Read insert (inside package) on how to: • get a new bottle ready (primed) before first use • prime bottle again if not used for more than 2 weeks • use the spray • clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older • once daily, spray 2 times into each nostril while sniffing gently • once your allergy symptoms improve, reduce to 1 spray in each nostril per day CHILDREN 2 TO UNDER 12 YEARS OF AGE • the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year. children 6 to under 12 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently • if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day. children 2 to under 6 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently children under 2 years of age • do not use • do not use more than directed • if you forget a dose, do not double the next dose • do not spray into eyes or mouth • if allergy symptoms do not improve after one week, stop using and talk to a doctor • do not use for the common cold • shake well before each use
Warnings
openFDA Drug LabelingWarnings Do not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you • have had recent nose ulcers or nose surgery • have had a nose injury that has not healed • are using a steroid medicine for asthma, allergies or skin rash • have an eye infection • have or had glaucoma or cataracts When using this product • the growth rate of some children may be slower • some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. • do not share this bottle with anyone else as this may spread germs • remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Do Not Use
openFDA Drug LabelingDo not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients
Ask a Doctor
openFDA Drug LabelingWhen using this product the growth rate of some children may be slower some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. do not share this bottle with anyone else as this may spread germs remember to tell your doctor about all the medicines you take, including this one
Stop Use
openFDA Drug LabelingStop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds
Active Ingredient
openFDA Drug LabelingActive ingredient (in each spray) Triamcinolone acetonide 55 mcg (glucocorticoid)
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: TRIAMCINOLONE ACETONIDE. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 59779-746-01 | 59779-746 | CVS Pharmacy | 1 BOTTLE, SPRAY in 1 CARTON (59779-746-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY | April 10, 2016 |
| 59779-746-02 | 59779-746 | CVS Pharmacy | 1 BOTTLE, SPRAY in 1 CARTON (59779-746-02) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY | May 1, 2017 |
| 59779-746-03 | 59779-746 | CVS Pharmacy | 2 BOTTLE, SPRAY in 1 CARTON (59779-746-03) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY | December 13, 2016 |
| 37808-443-01 | 37808-443 | H E B | 1 BOTTLE in 1 CARTON (37808-443-01) / 120 SPRAY, METERED in 1 BOTTLE | March 30, 2017 |
| 42507-443-01 | 42507-443 | HyVee Inc | 1 BOTTLE, SPRAY in 1 CARTON (42507-443-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY (42507-443-00) | December 30, 2016 |
| 30142-813-01 | 30142-813 | Kroger Company | 1 BOTTLE, SPRAY in 1 CARTON (30142-813-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY | March 17, 2020 |
| 30142-813-03 | 30142-813 | Kroger Company | 2 BOTTLE, SPRAY in 1 CARTON (30142-813-03) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY | March 9, 2021 |
| 0536-1457-69 | 0536-1457 | Rugby Laboratories | 1 BOTTLE, SPRAY in 1 CARTON (0536-1457-69) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY | November 11, 2025 |
| 21130-613-02 | 21130-613 | Safeway | 1 BOTTLE, SPRAY in 1 CARTON (21130-613-02) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY | August 1, 2025 |
| 59779-746 | 59779-746 | CVS Pharmacy | — | April 10, 2016 |
| 37808-443 | 37808-443 | H E B | — | March 30, 2017 |
| 42507-443 | 42507-443 | HyVee Inc | — | December 30, 2016 |
| 30142-813 | 30142-813 | Kroger Company | — | March 17, 2020 |
| 0536-1457 | 0536-1457 | Rugby Laboratories | — | November 11, 2025 |
| 21130-613 | 21130-613 | Safeway | — | August 1, 2025 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
Generated September 25, 2026 · 10 sections on this page.